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effective technologies for DNA delivery,[1] 
and the ability to transfer and express exog-
enous genes in mammalian cells.[3,4] After 
the approval of the first gene therapy agent 
in 2012 by the European Medicines Agency 
(EMA), this field became a prominent issue 
of research[5] for therapeutic, prophylactic, 
or diagnostic approaches related directly to 
the recombinant nucleic acid sequence.[6]
The strategy has expanded from the 
plasmid DNA (pDNA) transference to mes-
senger RNA (mRNA), microRNA (miRNA), 
and small interfering RNA (siRNA),[4,7] 
although different therapeutic payloads 
require different tailor-made carriers, thus 
complicating preclinical development.[8] 
The large size of pDNA (300–400 nm of 
hydrodynamic diameter), for instance, is 
one characteristic that differs in the tai-
loring between RNA and DNA. Besides 
the physical difference, the site of action in 
cells also changes from siRNA to pDNA. 
In siRNA, the downregulation of proteins 
occurs in the cytoplasm, whereas pDNA 
delivery results in protein production, which 
initiates in the cell nuclei with pDNA transcription.[5] For effective 
pDNA delivery and transcription, polycations are good candidates 
providing pDNA stability and uptake by the target cells.[9]
The large size of pDNA and its short half-life in the pres-
ence of serum proteins are a challenge in nucleic acid delivery 
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1. Introduction
Gene therapy is a concept originally conceived in around 
1970,[1,2] as a consequence of the exponential growth in the 
knowledge of human gene function, the development of more 
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as it is necessary to pack this nucleic acid into vesicles or nano-
particles.[5,7] Moreover, the easy plasmid unpacking from poly-
plexes in the cytoplasm is necessary, so that DNA is accessible 
to transcription factors for gene expression.[10]
Cationic polymers can be considered perfect noncovalent 
interaction partners for nucleic acids, providing similar size 
dimensions but opposite ionic charge.[8] Frequently studied 
cationic polymers include poly(l-lysine), chitosan, dendritic 
polymers,[11,12] and polyethyleneimine (PEI).[13,14] The synthetic 
pentamines and hexamines in PEI are more effective in con-
densing DNA.[15,16] Although PEI has proven to be efficient and 
versatile, and clinical trials suggest that PEI-based complexes 
have a good safety profile, this polymer is not degradable[17] 
and is significantly toxic in a molecular weight-dependent 
manner.[7,13]
Unlike most of poly(amino acid)s that are prepared by ring-
opening polymerization of N-carboxyanhydrides (NCAs), a bio-
degradable and water-soluble poly(aspartic acid) (PASP) can be 
directly obtained from alkaline hydrolysis of poly(succinimide) 
(PSI),[18] which is a poly(imide) obtained from thermal polycon-
densation of aspartic acid (ASP).[19,20] Aminolysis of PSI with 
nucleophilic amine-bearing compounds is used to form various 
poly(asparamide)s with side groups like isopropylasparamides 
segments, thus obtaining a thermoreversible phase transition 
polymer,[19] biodegradable water-soluble polymeric materials,[21] 
reversible micelles,[22] PEI-mimetic polymers,[20] and pseudo-
branched PEI.[23] These copolymers can form aggregates, 
micelle-like structures,[24–26] and can be used as drug and gene 
delivery systems.[27,28]
Protonable nitrogens within amine groups have been iden-
tified as main components in the rational design of nonviral 
vectors for gene delivery[29] such as cationic polymers that can 
be combined with DNA to form a particulate complex, con-
densing and shielding the DNA from enzymatic degradation.[29] 
Although polymer binding the DNA requires sufficient charge, 
excess of positive charges leads to high-levels of cytotoxicity 
due to unspecific interactions with serum molecules or cellular 
membranes.[29]
Polymer hydrophobicity is frequently an underappreci-
ated factor for successful gene delivery despite of its role 
in improving DNA binding through strengthening interac-
tions with genetic material and interaction with cell mem-
branes.[16,30,31] Biodegradable amphiphilic copolymers with 
hydrophobic moieties have been synthesized by partial aminol-
ysis of PSI with dodecylamine and propylamine for aggregates 
formation.[32] Studies of O’Keeffe et al. (2018),[30] for instance, 
showed an increased DNA binding in their dodecylated deriva-
tives compared to their non-dodecylated counterparts resulting 
in higher gene transfection efficiency. Since hydrophobic inter-
actions play a significant role in polymer binding strength,[33] 
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Figure 1. Synthesis of PSI derivatives. a) Synthesis of PSI (1) from l-ASP. b) Synthesis of dodecylated PSI (2), degree of substitution (DS) 10 mol%. 
c) Synthesis of dodecylated PSI (2). d) Synthesis of dodecylated PSI polycations. e) Amines An used for aminolysis of 1 and dodecylated PSI (2), thus 
obtaining polycations 1An and 2An. f) Non-dodecylated PSI derivatives (1An group) and their dodecylated counterparts (2An). The dodecyl side chain 
is represented in red in the copolymers.
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aggregation,[19] stacking of nucleotide bases in double-strand 
DNA,[34] the dodecyl side chain has an influence in the binding 
process and gene expression in gene therapy with polyplexes.[30] 
DNA binding with a polycation is described as a coacervate, a 
complex of polyelectrolytes[35] and is mainly formed via elec-
trostatic interactions. Moreover, a higher degree of interaction 
with the plasmid via Van der Waal’s interactions/modulation 
has been reported to facilitate interactions between the polymer 
backbones and DNA in previous studies.[33]
Here, we synthesized a systematic series of hydrophobi-
cally modified PSI polycations to screen efficient complexing 
agents and to investigate their binding behavior in plasmid 
DNA delivery. PSI was grafted with dodecylamine and then 
reacted with different amine moieties, which provided non-
dodecylated and dodecylated cationic polymers. Plasmid activity 
was screened via green fluorescent protein (GFP) expression 
after pEGFP-N3 plasmid complexation and transfection in 
HeLa cells.
2. Results and Discussion
2.1. Polymers Synthesis and Characterization
To elucidate the ability of polyplex formation of dodecylated 
and non-dodecylated PSI derivatives, we synthesized a series 
of polycations with different amine moieties. Figure 1 presents 
the synthesis of PSI derivatives along with the synthesized PSI 
grafted with cationic moieties (1An group, non-dodecylated 
polycations) and dodecylated PSI derivatives with cationic moi-
eties (2An group).
PSI (1) is a poly(imide), a precursor for PASP, a biodegrad-
able and biocompatible polymer as poly(γ-glutamic) acid and 
poly(ε-lysine). Table 1 shows all chemical shifts of PSI and 
PSI derivatives, and the spectra are presented in Figures S1–
S5, Supporting Information. PSI synthesis is confirmed with 
three characteristic peaks in 3.2 and 2.69 ppm (methylene) and 
5.25 ppm (methine), related to the succinimide ring.[19,32]
Table 2 provides the ratio (R) between dodecyl side chains 
and amines and the degree of substitution of grafted amines An 
(DSA). The partial aminolysis of PSI units with dodecylamine 
(10 mol%) and the total ring opening of PSI units would result 
in a new signal at 4.5 ppm assigned to the methine proton of 
N-dodecylamide units, as observed in previous studies.[32]
For this study, the actual dodecylamine ratio found was 
≈12 mol% and both PSI and its dodecylated copolymers grafted 
with amines An resulted in a total aminolysis and ring opening 
of PSI backbone, observed with the chemical shift of methine 
protons signal at 5.25 ppm to a new signal at 4.5 ppm. DS of 
dodecylated PSI was obtained from the integrated area ratio of 
the signals at 0.89 and 5.25 ppm, assigned to the methyl group 
of the dodecyl side chain and the methine of succinimide unit, 
respectively. As partial or complete racemization is expected 
to occur during the PSI synthesis, grafted PSI shows the split 
NMR signals due to the stereoregularity differences, and the 
disappearance of peak at 5.25 ppm and two chemical shifts 
values of methine protons at 4.5 were caused by an α- and β-
ring opening.[36,37]
Moreover, high grafting ratios were successfully achieved 
with aminolysis of PSI and dodecylated PSI (2) and the ring 
opening α:β ratio was calculated from the integral area ratios 
of methine peaks at 4.65 (α-CH) to 4.48 ppm (β-CH).[23] Table 3 
shows the different ratios for the PSI derivatives and the 
α-opening predominance, as observed in previous studies with 
PSI grafted with bPEI.[23] Mole ratios were calculated by inte-
grating the peaks 4.65 and 4.48 ppm.
We determined the molecular weights of the polymers by 
size exclusion chromatography (SEC) analysis. Here, non-
dodecylated polymer group had higher weight average mole-
cular weight (Mw) values than 2An (Table 4) presumably due 
to the hydrophobic intra- and intermolecular interactions of 
dodecylated polymers and fewer interactions with water mole-
cules. The polydispersity index (PDI) of all non-dodecylated PSI 
derivatives (polycations group 1An) did not show a clear trend 
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Table 1. 1H NMR chemical shifts of PSI (1), dodecylated PSI (2), and 
polycationic polymer groups 1An and 2An.
Nucleus 1H NMR shift [ppm] Attribution
a 5.25 t, 1H
b 2.69 and 3.2 s, 2H
c 2.8 —
d 1.5 s, 2H
e 1.17 s, 18H
f 0.86 s, 3H
g 1.65 s, 4H
h 2.13 s, 6H
i 2.17–2.25 —
Table 2. Ratio (R) in mol% of dodecylamine (C12) and cationic moieties 
in 2An PSI derivatives.
Polycation 2A1 2A2 2A3 2A4
R, [mol%] x (C12):y (An) 0.22:1 0.24:1 0.33:1 0.29:1
DSC12 [mol%]a) 18 19 24 22
PSIb) (opened rings), [mol%] 10 — — —
DSC12c) [mol%] 8 9 14 12
DSAd) [mol%] 82 81 76 88
a)Degree of substitution (DSC12) in mol% calculated from the ratio obtained after 
total aminolysis of dodecylated PSI. Value based on 1H NMR analysis; b)Feed ratio 
of dodecylamine (theoretical); c)Actual ratio of dodecylamine. Value based on 1H 
NMR analysis; d)Actual DSA in mol% in 2An polycations. Value based on 1H NMR 
analysis.
Table 3. α- and β-opening of succinimide rings of PSI (1) and 
dodecylated PSI (2) in the polycation groups 1An and 2An after total ami-
nolysis process.
1An group 2An group
1A1 1A1 1A3 1A4 2A1 2A2 2A3 2A4
α 0.8 0.8 0.67 0.7 0.68 0.70 0.47 0.54
β 0.17 0.19 0.33 0.3 0.28 0.28 0.50 0.42
α:β 4:1 4:1 2:1 2:1 2.5:1 2.5:1 1:1 1:1
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with the selected amine used for the PSI grafting. The same 
behavior was not found for the 2An group, in which a distribu-
tion of PDI values was found from 2 to 4. Moreover, the PDI 
values increased with the presence of the alkyl chain.
The polymers were titrated with HCl to obtain buffering 
capacity (β) profiles (Figure 2). In this measurement, polymers 
with a higher buffering capacity need larger amounts of HCl 
for their pH alteration. A reduction of buffering capacity is fre-
quently associated with hydrophobic modifications.[38,39] The 
decrease or increase of buffering capacity is highly associated 
with conjugation strategies used in the grafting of PEI, since 
conjugation methods, in that case, lead to a conversion of sur-
face primary amines to secondary amines, thus reducing the 
buffering capacity.[39] Here, the hydrophobization of PSI back-
bone led to substantial increase in the buffering capacity of 
polymers. Besides, non-dodecylated and dodecylated PSI deriv-
atives had higher values than bPEI 25 (about 24%), the same 
value observed previously.[40]
As shown in Figure 2, the grafting of the dodecyl group in 
the PSI backbone structure changed the buffering capacity pro-
file of PSI derivatives. Dodecylation in A2- and A4-based PSI 
derivatives provided substantial changes in the buffering pro-
file, as also observed in Table 4. Buffering capacity values were 
higher for all polymers except for 2A3 and 2A1, the latter with 
a slightly lower value when compared with its non-dodecylated 
Macromol. Biosci. 2019, 19, 1900117
Figure 2. Acid–base titration profiles of PSI derivatives 1An and 2An groups in 150 mm NaCl solution. The difference between groups is the presence 
of a dodecylamine side chain (DS 12 mol%) in the PSI backbone of 2An polycations group. bPEI 25 was used as a control.
Table 4. Characteristics of PSI derivatives.
Mw Mn Mz PDI N% N β CMC
Non-dodecylated polycations
1A1 16.1 7.4 46.4 2.2 9.83 70.2 39.30 1
1A2 19.6 9.7 34.5 2.0 7.7 55 32.92 1.03
1A3 17.3 7.2 35.6 2.4 11.54 82.4 66.96 0.62
1A4 25.7 9.4 57.5 2.7 12.61 90.1 40.20 0.64
Mw Mn Mz PDI N% N β CMC
Dodecylated polycations
2A1 8.6 2.7 19.8 3.0 6.14 43.9 41.28 0.5
2A2 5.4 2.2 10.8 2.4 5.16 36.9 49.12 0.27
2A3 5.5 2.2 12.3 2.5 7.61 54.4 49.96 0.22
2A4 8.1 1.9 11.4 4.3 8.39 59.9 60.43 0.24
Molecular weights and molecular weight distributions were determined by GPC 
and elemental analysis (EA) was performed for the determination of total nitrogen 
amount (N%) and nitrogen content in 10 mg polymer (N, µmol); bPEI 25 values 
N% 31.89 (3.19 µmol). Buffering capacity (β, %) of PSI polycations and bPEI 25 in 
the pH range 7.4–5.1 (β for bPEI 25, 23.85%). Critical micellar concentration (CMC) 
values of dodecylated and non-dodecylated PSI derivatives, mg mL−1. For conveni-
ence, we described the 1:3 ratio as I3/I1 ratio versus log of polymer concentration. 
Mw, weight-average molecular weight (kDa); Mn, number-average molecular weight 
(kDa); Mz, volume-average molecular weight (kDa). PDI = weight-average mole-
cular weight/number-average molecular weight, or Mw/Mn.
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counterpart. Also, the presence of the dodecyl side chain in the 
backbone of 2A3 derivative had decreased the buffering capacity 
of the derivative, suggesting a dual control of hydrophobicity 
and amine moiety in the buffering capacity.
Ong et al. (2018) suggest in their studies that a longer and 
thus more hydrophobic alkyl moiety grafted in a polymer back-
bone contributes to a higher degree of interactions with DNA 
molecules possibly via Van der Waals interactions.[33] A low 
level of long hydrophobic substitutions such as dodecyl moie-
ties may be sufficient to facilitate stronger hydrophobic inter-
actions, inducing inter and intra hydrophobic–hydrophobic 
associations,[41,42] and changing the overall available protonable 
amine in the polymer, since the latter would be in a micelle-like 
state during the measurement. A dynamic protonation state 
might change the overall charge in the polymers[41] and modu-
late the orientation of protonable amines.
Previous studies related endosomal escape of polyplexes 
to the buffering effect associated to the amino groups in the 
constituent polycations and proton sponge hypothesis,[43] thus 
it is recommended that the buffering capacity might need to 
be balanced by controlling the type of amine and the size and 
degree of substitution of alkyl side chain, with all other polymer 
properties.[10] It is also indicated that the proper reduction of 
buffer capability could enhance the in vitro transfection effi-
ciency, as DNA could be released easily from the complexes.[20]
The critical micellar concentration (CMC) of all PSI deriva-
tives and bPEI 25 was determined (Figure 3). It is known that 
increasing the hydrophobicity of a polymer chain to a certain 
degree would facilitate micellization of amphiphilic polymers 
and a minimal hydrophobicity is indicated for bPEI 25.[44] 
Here, the CMC of all polycations 1An and 2An was determined 
according to previous studies,[45,46] and for convenience, we 
describe the 1:3 ratio as I3/I1 ratio versus log of polymer con-
centration. Micellar formation occurred in lower polymer con-
centrations in the case of the 2An group. bPEI 25 was used 
as a standard complexing agent and its CMC could not be 
Macromol. Biosci. 2019, 19, 1900117
Figure 3. CMC of dodecylated and non-dodecylated PSI-based polycations. Grid lines show CMC of 1A1, 1 mg mL−1 and 2A1, 0.5 mg mL−1; 1A2, 
1.03 mg mL−1 and 2A2, 0.27 mg mL−1; 1A3, 0.62 mg mL−1 and 2A3, 0.22 mg mL−1; 1A4, 0.64 mg mL−1 and 2A4, 0.24 mg mL−1. For convenience, we 
described the 1:3 ratio as I3/I1 ratio versus log of polymer concentration.
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detected.[44,47] Increasing the hydrophobicity of PSI backbone 
with alkyl segments to a certain degree facilitated micellization 
of amphiphilic polymers.[28]
Cytotoxicity of all polycations was concentration-dependent 
(Figure 4). The presence of the hydrophobic dodecyl side chain 
in the PSI backbone did not decrease the cell viability up to a 
concentration of 250 µg mL−1, suggesting that the hydrophobic 
moieties do not increase cytotoxicity in the range of polymer 
concentrations. To confirm the non-toxicity of the alkyl chain in 
the polymers, cytotoxicity assays of bare dodecylated PSI deriva-
tives obtained after amylolysis with amines 1-(3-aminopropyl) 
imidazole (A5) and 1-(2-aminoethyl) piperazine (A6) were per-
formed (Figure S6, Supporting Information). Both imidazole 
and piperazine have lower in vitro cytotoxicity and are used in 
polymer and drug design.[48–50] For the imidazole side chain 
(A5), higher cell viability was obtained until 250 µg mL−1, and 
a decreased cell viability was observed for the piperazine side 
group (A6), presumably due to the secondary amine in the pip-
erazine ring.
For polycations of A3 and A4 group, increased toxicity was 
observed, clearly dependent on the increase of polymer concen-
tration. Both amines are ethyleneimine-based structures, PEI 
components, although PSI derivatives with those amines had 
lower toxicity than bPEI in the concentration range from 0.025 
to 25 µg mL−1 and from 0.025 to 2.5 µg mL−1 for A3 and A4 
grafted PSI, respectively. For transfection assays, the concentra-
tion range was between 2 and 20 µg mL−1.
2.2. Physicochemical Properties and DNA Binding Ability
All PSI derivatives were mixed with plasmid DNA (pEGFP-N3) 
and the DNA condensation ability of each polymer at different 
N/P ratios was studied by gel retardation assay. The extent of 
condensed pEGFP-N3 is a determining factor in different trans-
fection efficiencies in PEI-based polyplexes,[51] and inhibition of 
transcription can occur either if the plasmid is tightly or loosely 
condensed.[52]
According to the gel retardation assay (Figure 5a–d), an 
optimal N:P ratio of 2 was obtained for A2- and A3-based PSI 
polycations, and an N:P 5 for A1 and A4 derivatives. Both 1A2 
and 2A2 structures differ from the A1 group on two methyl 
end groups in the A2 moiety, providing more interactions 
with pEGFP-N3 plasmid via hydrophobic binding, decreasing 
the N:P ratio. Despite the fact of fewer aminoethylene repeats 
in the side chain of polycations, 1A3-based polyplexes were 
Macromol. Biosci. 2019, 19, 1900117
Figure 4. Cytotoxicity of bare PSI derivatives in HeLa cells. Cells were treated with increasing polymer solution until 250 µg mL−1. Grid line represents 
IC50 3.95 µg mL−1 for bPEI 25. Error bars represent the s.d. (n = 3).
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formed at lower N:P than those obtained with polycation 1A4. 
Both amines share the same protonation status at pH 7.2 with 
two protonated amino groups per side chain.[53] Dodecylated 
A3- and A4-based polyplexes were formed at the same N:P ratio 
of 2.
To evaluate the binding strength of PSI derivatives and 
polyplex integrity, heparin displacement assay was performed. 
In this experiment, the amount of uncomplexed plasmid is 
accessed once free double-stranded DNA can be detected after 
displacement of DNA from polyplexes by different concentra-
tions of heparin using a commonly described method.[54] For 
bPEI 25, the optimal complexation ratio is N:P 5, and pEGFP-
N3 was displaced by heparin from concentrations above 0.6 IU 
per sample (Figure S7, Supporting Information).
Macromol. Biosci. 2019, 19, 1900117
Figure 5. Evaluation of plasmid DNA binding ability and binding strength of cationic PSI derivatives. a–d) Electrophoretic mobility of pEGFP-N3 
plasmid in pEGFP-N3/1An and pEGFP-N3/2An polyplexes at N:P 0.5–20, and e–h) displacement of pEGFP-N3 from the polyplex with increasing con-
centrations of heparin from 0.2 to 1 IU.
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Figure 5e–h shows that fluorescent intensities for all non-
dodecylated-based polyplexes slightly increased at low heparin 
concentrations with a rise above 0.4–0.6 IU per sample. At 1 IU 
per sample, a complete displacement from the pEGFP-N3/1An 
polyplexes is observed. Interestingly, fluorescence intensities 
for all dodecylated polyplexes at N:P 5 significantly decreased at 
all heparin concentrations, except for amine A2.
These results suggest that the hydrophobic alkyl moieties 
present in the side chains of PSI contributed to the increase 
of polymer/DNA polyplexes interaction[55] via Van der Waal’s 
interactions/modulation, which have been reported to facili-
tate interactions between the polymer backbones and DNA in 
previous studies.[33] Although an efficient gene delivery can be 
observed in polyplexes with strong pDNA binding via hydrogen 
bonding,[54] the presence of an alkyl chain can modulate the 
integrity of polyplexes by hydrophobic interactions, increasing 
the binding between the polymer and the DNA.
Size and surface charge of polyplexes were determined 
by DLS and zeta potential measurements. Size and residual 
charge measurements of bPEI 25 polyplexes were performed 
(Figure S8, Supporting Information). The size of the complexes 
for all N:P ratios was around 100 nm, although the polydisper-
sion index (PDI) is optimal at N:P 5 for these polyplexes, as 
observed in Figure 6a–d.
The presence of the dodecyl side chain in the PSI deriva-
tives did not change the size of the polyplexes obtained from 
PSI grafted with amine A1 and A2. Both groups present similar 
values for size and the same PDI profile with an optimal N:P 
ratio of 5. However, for the A3 grafted PSI, polyplex sizes of the 
2An group were smaller than those from 1An, from N:P ratio 
0.5 to 1. The opposite was observed for N:P ratios higher than 
2, in which pEGFP-N3/2A3 polyplexes had larger sizes than 
pEGFP-N3/1A3 polyplexes. PDI values were also optimal at N:P 
ratios of 5 and 10. Furthermore, at N:P 2 large aggregate forma-
tion was observed, possibly due to a decreased colloidal stability 
induced by charge neutralization for all polyplexes. pEGFP-
N3/2A4 polyplexes had a lower size than pEGFP-N3/1A4 at 
N:P ratios 0.5 and 1 with high PDI. From N:P 5, this behavior 
changes and pEGFP-N3/1A4 particles had smaller sizes than 
pEGFP-N3/2A4. PDI values for all polyplexes reduced as N:P 
ratio increased.
Regarding zeta potential measurements (Figure 6e–h), par-
ticles with a zeta potential higher than 30 mV are physically 
more stable due to the presence of electrostatic repulsion.[55] 
Zeta potential values of pEGFP-N3/bPEI25, pEGFP-N3/1An, 
and pEGFP-N3/2An polyplexes have a charge inversion between 
N:P ratios 0.5 and 1, from a negatively to a positively charged 
polyplex.
2.3. Cytotoxicity of Polyplexes
In vitro transfection and GFP expression assays showed N:P 
5 as optimal ratio for transfection for synthesized polycations. 
For all polymers, an N:P 5 was chosen for the assessment of 
the viability of HeLa cells after treatment with polyplexes 
using the MTT assay, in which polyplex volumes ranged from 
25 to 100 µL, the same volumes used for transfection assays. 
Figure 7 presents the viability of HeLa cells after polyplex 
treatment. As expected, lower polyplexes volumes 25 and 50 µL 
caused no change in the cell viability in all polyplexes with syn-
thesized dodecylated and non-dodecylated PSI derivatives or 
bPEI 25. Cell toxicity slightly increased for higher volumes 75 
and 100 µL of dodecylated PSI derivative polyplexes, suggesting 
an increase of cell cytotoxicity due to the excess of free amines 
in the polyplexes after hydrophobic intra- and intermolecular 
polymer–polymer and polymer–pDNA interactions.
2.4. In Vitro Transfection Efficiency of pEGFP-N3/1An and 
pEGFP-N3/2An Polyplexes
In vitro transfection efficiency of all polyplexes was assessed 
to find the optimal PSI derivative among non-dodecylated and 
dodecylated synthesized polycations. Here, HeLa cells were 
treated with polyplexes in serum-free medium for 6 h and then 
left for another 42 h in complete medium until quantification 
of GFP expression by flow cytometry. To optimize the pEGFP-
N3 transfection and GFP expression in HeLa cells, a series of 
pEGFP-N3/bPEI 25 polyplexes in different ratios and volumes 
was prepared (Figure S7, Supporting Information). A volume of 
25 µL of pEGFP-N3/bPEI 25 N:P 5 polyplexes was considered 
to be the optimal transfection ratio and volume for HeLa cells 
transfection and GFP expression.
A dose of polyplexes and N:P ratio variation was undertaken 
to understand further both polyplex amount and the optimal 
ratio between polycation and the plasmid in the transfection 
efficiency, which directly play a role in the GFP expression 
inside the cells. Figures S10–S13 (Supporting Information) 
demonstrate the entire panel with transfection ability of all 
non-dodecylated and dodecylated polycations.
The percentage of GFP expressing HeLa cells after transfec-
tion with pEGFP-N3/1A4 polyplexes was the highest among 
non-dodecylated and dodecylated polycations (≈48% compared 
to ≈20% of bPEI 25 at the same conditions, N:P 5 and 50 µL 
polyplex volume) (Figure 8). Previous studies showed that A4 
amine possessing even-numbered repeating aminoethylene 
units provided significantly higher transfection efficiencies 
than odd-numbered repeating units such as A3 in Huh-7, A549 
and HUVEC cells.[43] In our studies with HeLa cells, pEGFP-
N3/1A3 polyplexes also provided lower GFP expressing HeLa 
cells percentage than A4-based non-dodecylated polycation. 
pEGFP-N3/1A3 polyplexes showed higher GFP expressing cells 
at N:P 10 and 100 µL (≈42% compared to ≈4.5% of bPEI 25). In 
previous studies, Uchida et al.[43] associated the precise spacing 
between protonated amino groups in A3 and A4 structures to 
be essential for facilitating the transport of polyplexes into the 
cytoplasm.
The percentage of GFP expressing HeLa cells after pEGFP-
N3/1A1 transfection was the highest among non-dodecylated 
and dodecylated A1 and A2-based polycations (≈13% compared 
to ≈15% of bPEI 25 in the same N:P 5 and 50 µL polyplex 
volume). These two amines share the same structure, except 
for two terminal methyl groups. The combination of these two 
diaminoethane side chains in different ratios in the PSI back-
bone has been previously compared regarding binding ability 
and GFP expressing B16BL6 cells[20] showing that tertiary 
amines may be required for better transfection efficiencies 
Macromol. Biosci. 2019, 19, 1900117
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as seen for bPEI 25. Here, a slightly higher GFP expressing 
cells percentage was found in the dodecylated 2A2 polycation 
compared to its non-dodecylated counterpart. The presence of 
dodecylamine side chain in the PSI backbone of polycation 2A2 
led to an increased GFP transfection, the opposite behavior of 
A1-grafted PSI polycation.
Uchida et al.[53] showed that binding ability and translational 
efficiency of mRNA of A1 amine in PSI polyions was compa-
rable to naked mRNA and significantly higher than A3. Poly-
cations 1A1 and 1A2 possess two amino groups in the side 
chain that at pH 7.4 are in double-protonated form in the 1A1 
(pka1 = 9.7 and pka2 = 8.6) and single-protonated form in the 
Figure 6. 1An and 2An polyplexes with pEGFP-N3: hydrodynamic diameter Dh (nm) and polydispersity index (PDI) by DLS in HEPES buffer at 25 °C. 
Measurements were performed in triplicate; intensity average mean value is presented. Grid lines with * represent that no data was obtained for the 
N:P ratio.
www.advancedsciencenews.com www.mbs-journal.de
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1A2 (pka1 = 9.7), the latter with a tertiary amine with lower 
pKa value. Additionally, 1A1 relieves the electrostatic repulsion 
allowing a double-protonated structure at pH 7.4, an event that 
probably is undesirable for the higher GFP expressing cells 
among A1 and A2 polymers, since no protonable amines are 
available for the endosomal escape inside the cells.
Dodecylated PSI derivatives in the polyplexes pEGFP-N3/2An 
showed stronger binding between the nucleic acid and the poly-
mers, except for pEGFP-N3/2A2 in which the release of DNA 
occurred with 0.2 to 1 IU of heparin per sample, a range of 
heparin concentration that decreased the integrity of polyplex 
and released the DNA. No release of the DNA from the poly-
plexes was observed in the range of heparin concentration for 
all other polyplexes.
In summary, dodecylated polycations provided lower CMC 
due to the higher polymer–polymer interactions, confirmed 
by lower molecular mass in the SEC measurements. How-
ever, the presence of this alkyl side chain did not interfere in 
polyplexes size and charges. Indeed, hydrophobization led 
to higher poly mer–DNA interaction possible due to Van der 
Figure 7. Cytotoxicity of pEGFP-N3/1An and pEGFP-N3/2An polyplexes at N:P 5 in HeLa cells. Cells were treated with increasing pEGFP-N3/1An and 
pEGFP-N3/2An polyplex volumes a) 25 µL, b) 50 µL, c) 75 µL, and d) 100 µL. MTT test was performed after 6 h treatment. Grid line represents 50% 
relative viability. Error bars represent the s.d. (n = 3). e) Final polycation concentration equivalent to polymer volume at N:P 5.
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Figure 8. GFP expressing HeLa cells after 48 h treatment with 50 µL pEGFP-N3/1An and pEGFP-N3/2An polyplexes at different N:P. pEGFP-N3/bPEI 
25 polyplexes were used at the same N:P 5 and 50 µL as a positive control. Data are mean ± s.d. (n = 3 per group) analyzed by Student’s t-test (n = 3 
per group), all data with Tukey’s correction. NS, not significant; *p < 0.05, **p < 0.01, ***p < 0.005, and ****p < 0.001.
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Waal’s interactions associated with the amine-phosphate charge 
interaction, decreasing transfection presumably due to the lack 
of intracellular DNA release. Although additional molecular 
assessments are essential to elucidate details of this mecha-
nism, dodecyl side chains at the backbone of cationic PSI 
derivatives seem to be indispensable to the stability of poly-
plexes structures due to the higher binding strength between 
dodecylated polycations and pEGFP-N3, and may contribute to 
the protection of pDNA from nuclease attack. In vivo studies 
may show a different transfection efficiency profile. Increased 
polymer–DNA interactions via dodecylation may provide in 
vivo more extended polyplex circulation in blood as well as 
higher stability toward disassembly mediated by protein corona 
or even degradation by DNAses.
3. Conclusion
Polycations based on the polysuccinimide structure were 
synthesized for pDNA delivery. All polymers had lower 
cytotoxicity in HeLa cells when compared to bPEI 25. Hydro-
phobization of polycations decreased the critical micellar 
concentration of all polycations with no changes in the 
physicochemical properties such as size and charge. Also, 
GFP expressing cells percentage decreased after dodecylated 
PSI polyplexes transfection after 48 h. A possible explana-
tion is the hydrophobic interactions between plasmid and 
the dodecylated polycations via Van der Waal’s interactions. 
With further optimization, it is envisaged that dodecylated 
polymers may play a role in other lipid-based nanocon-
structs and also in co-delivery of genes and other lipophilic 
drugs.
4. Experimental Section
Materials and Chemicals: l-aspartic acid (ASP), dodecylamine (DDA), 
N-dimethyldipropylenetriamine (DMAPAPA), bis (3-aminopropyl) amine 
(norspermidine), triethylenetetramine (DEH), tetraethylenepentamine 
(TEPA), branched polyethyleneimine 25 kDa (bPEI 25), 1-(3-aminopropyl)
imidazole, 1-(2-aminoethyl)piperazine, 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyl-2H-tetrazolium bromide (MTT), 4-(2-hydroxyethyl)piperazine-
1-ethanesulfonic acid, N-(2-hydroxyethyl)piperazine-N′-(2-ethanesulfonic 
acid) (HEPES), antibiotics, orthophosphoric acid (H3PO4) 85 wt% in 
water, deuterated solvents (d6-DMSO, D2O), N,N-dimethylformamide 
(DMF), and methanol were purchased from Sigma-Aldrich (Steinheim, 
Germany) unless otherwise indicated. Water was used as purified, 
deionized water. As a pDNA vector, pEGFP-N3 from Clontech was used.
Synthesis of Poly(succinimide), (1): Poly(succinimide) (PSI) was 
obtained according to previously described procedures.[32,36] A thermal 
polycondensation of l-aspartic acid (ASP) was performed by mixing 
ASP (10 g, 75.1 mmol) with 12 mol% of orthophosphoric acid 85 wt% 
(H3PO4) (600 µL, 860 mg, 8.8 mmol) using a mortar and pestle. The 
mixture was taken to an oven at 200 °C, under vacuum, for 3 h. The 
yellowish crude product was dissolved in N,N-dimethylformamide 
(DMF), precipitated in methanol, filtered, washed with distilled water.
Synthesis of Poly(succinimide)-co-(N-Dodecylamide Aspartate), (2): Here, 
10 mol% of dodecylamine (236 µL, 191 mg, 1.03 mmol) were added to PSI 
(1000 mg, 10.3 mmol) pre-dissolved in dry DMF (5 mL), at 50 °C, and the 
reaction was kept for 5 h. The reaction mixture was precipitated in distilled 
water, washed with ethanol, and dried under vacuum at 40 °C for 24 h.
Synthesis of 1An and 2An Polycations: Aminolysis of PSI (1) and 
dodecylated PSI (2) with selected amines. Figure 9 shows aminolysis of 
PSI (1) and dodecylated PSI (2), with amines A1–A4. Both 1 and 2 were 
previously dissolved in DMF and slowly added with a syringe into the amine 
solutions dissolved in DMF. Reactions were kept for 1 h in an ice bath, 
then dialyzed with dialyzing tubes with molecular weight cut-off (MWCO) 
of 3 kDa in water for 48 h, and subsequently lyophilized. The polymers 
obtained were called 1An and 2An, according to the side chain amine.
1H NMR: 30 mg of PSI (1) and dodecylated PSI (2) were dissolved in 
deuterated DMSO (d6-DMSO). 1An and 2An polycations were dissolved 
Figure 9. Synthesis of poly(succinimide) (PSI) derivatives. a) Synthesis of PSI (1) from l-aspartic acid (ASP). b) Synthesis of dodecylated PSI (2), degree 
of substitution (DS) 10 mol%. c) Synthesis of dodecylated PSI (2). d) Synthesis of dodecylated PSI polycations. e) Amines An used for aminolysis of 1 
and dodecylated PSI (2), obtaining polycations 1An and 2An.
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in deuterated water (D2O). 1H NMR spectra were recorded using a 
Bruker AVANCE III 700 (700 MHz) device. Chemical shifts are reported 
in ppm and refer to the proper solvent as an internal standard. Data are 
reported as follows: s, singlet, d, doublet, t, triplet; m, multiplet. Spectra 
were analyzed using MestreNova by MestreNovaLab Research.
SEC: Number average molecular weight (Mn), weight average 
molecular weight (Mw), and higher average molecular weight (Mz) of 
all polymers were obtained from an UltiMate 3000 LC System (Thermo 
Scientific) with photodiode array (PDA)—UV detector and Shodex 
RI—101 detector (Showa Denko America, Inc.), with Zenix SEC-100 
Sepax column. Sodium acetate 0.3 m, pH 4.40 was used as eluent, and 
a flow rate of 0.8 mL min−1 and 40 °C were set. The injection volume of 
the sample was 50 µL. Dextran standards for calibration: Mw 12 kDa, 
50 kDa, 80 kDa, 150 kDa, and 670 kDa.
Elemental Analysis (EA), Titration, and Buffering Capacities of 
Polycations: Elemental analysis of polymers was carried out by VARIO 
ELIII (Germany) elemental analyzer. For the quantification of protonable 
amine groups, a titration of all polycations was performed. For this, 
10 mg of dry material were dissolved in 30 mL 150 mm sodium chloride 
(NaCl) solution. pH was adjusted to 12 with 100 mm sodium hydroxide 
(NaOH) and then the polymers were titrated with 100 mm chloridric acid 
(HCl) to constant pH 2–3. Equation (1) was used to calculate buffering 
capacities of all polycations, in which ∆(HCl) is the volume of acid with 
concentration C used for the pH change in the range pH 7.4–5.1 and N is 




100β = ∆ × ×  (1)
CMC and Pyrene Fluorescence: CMC measurement was performed on a 
Jasco FP-6500 with the following settings: λex 335 nm, bandwidth 10 nm; 
λem 350–550 nm, band width 1 nm; data pitch 0.1 nm; data collection 
speed of 20 nm min−1; 25 °C. A stock solution of pyrene was prepared 
using the following procedure: 20 µL of a pyrene solution in methanol 
(3.5 mm) was evaporated in a 100 mL Erlenmeyer flask; 100 mL of ultrapure 
water was added and the solution was sonicated for 1 h and afterward 
filtered through a regenerated cellulose (RC) membrane (0.45 µm). A 
concentration series of each polymer was prepared using the pyrene stock 
solution. For each measurement, 1.5 mL were filled into a Quartz cuvette. 
I3/I1-ratio was calculated through the division of the amplitudes at I3, 
385 nm and I1, 374 nm.
Plasmid Amplification: pDNA was amplified in E. coli and purified 
using a Nucleobond Xtra Midi Kit (Macherey–Nagel). The concentration 
of plasmid was measured by ultraviolet (UV) absorption at 260 nm. The 
pDNA purity was assessed by measuring the A260/A280 ratios.
Polyplex Formation: Polyplexes were prepared in 350 µL final volume 
by adding dilutions of polycation in HEPES buffer (20 mm, pH 7.4) into 
a fixed amount of pDNA dilutions resulting in different N:P ratios (0.5, 
1, 2, 5, 10, and 20). N:P value means the ratio between the number 
of amines of the cationic polymer and the phosphates of the plasmid. 
Briefly, 131.25 µL of a 0.133 µg µL−1 dilution of pEGFP-N3 in HEPES 
buffer was transferred to a 500 µL vial, followed by the addition of 
polymer solution up to 350 µL final volume. For each N:P ratio, the 
same volume and a constant amount of DNA (17.5 µg) was used.
Electrophoresis Mobility Shift Assay: Agarose gels were prepared by 
dissolving 1.2 g of agarose in 20 mL of TAE buffer and heated up to 
100 °C. After addition of 5 µL of Midori Green Advanced DNA stain for 
the detection of the nucleic acid, the agarose solution was poured into 
the electrophoresis chamber. A volume of 10 µL of previously prepared 
polyplexes were mixed with 5 µL loading buffer and then the mixture 
added to the gel. Electrophoresis was performed at 120 V for 30 min.
Dynamic Light Scattering (DLS) Measurements—Particle Size and Zeta 
Potential: 350 µL of polyplexes were prepared and the size measurement 
was performed on a Malvern Zetasizer ZS in disposable micro 
UV-cuvettes at 25 °C. Measurements were carried out in the backscatter 
mode at 25 °C and using a Nd:YAG laser with 532 nm emission 
wavelength. Samples were prepared with HEPES buffer 20 mm pH 7.4. All 
samples were measured three times and the size distribution was plotted 
by intensity distribution. For zeta potential, polyplexes were mixed with a 
NaCl solution (NaCl 150 mm final concentration). All experiments were 
performed in triplicates (mean ± s.d., n = 3).
Polyanion Competition Assay: Previously prepared polyplexes were 
incubated in the presence of the increasing amount of heparin (0, 0.2, 
0.4, 0.6, 0.8, and 1 IU per 50 µL polyplex final volume) and incubated for 
1 h. Then, 10 µL of polyplexes + heparin were mixed with 5 µL loading 
buffer and the mixture added to the agarose gel. Electrophoresis was 
performed at 120 V for 30 min.
Cell Culture: HeLa cells were obtained from Leibnitz Institute 
DSMZ–German Collection of Microorganisms and Cell Cultures (#ACC 
57) and were cultured in in RPMI medium (Thermo Fisher Scientific) 
supplemented with 10% FBS (FBS Superior, Merck), 1% antibiotics 
(penicillin and streptomycin), and 1% nonessential aminoacids (NEAA). 
Cells were cultured in an incubator at 37 °C and 5% CO2.
Cytotoxicity of Bare Cationic Polymers: Relative viability of HeLa cells 
for all bare cationic polymer solutions was obtained after 24 h with MTT 
method. Briefly, cells were plated in a 96-well plate at 1 × 104 cells per 
well, in 100 µL RPMI containing 10% FBS. After 24 h, cells were treated 
with a serial dilution of polymers for more than 24 h. Then, the medium 
was replaced with 200 µL of new medium containing 0.5 mg mL−1 
MTT and cells were incubated for 3 h. Wells were replaced with 100 µL 
isopropanol-HCl and the absorbance measured in Tecan Infinite M200 
Pro microplate reader at 570 nm. Relative viabilities were calculated 
according to the equation [A]test/[A]control × 100, in which A is absorbance 
and untreated cells served as a control. All experiments were performed 
in triplicates (mean ± s.d., n = 3).
Cytotoxicity of Polyplexes: Relative viabilities of HeLa cells incubated 
with all polyplexes were obtained after 6 h by MTT assay. Briefly, cells 
were plated in a 24-well plate at 5 × 104 cells per well, in 500 µL medium 
containing 10% FBS. After 24 h, cells were treated with 25–100 µL of 
polyplexes N:P 0.5–20 for 6 h. Then, the medium was replaced with 
500 µL of new complete medium containing 0.5 mg mL−1 MTT and cells 
were incubated for 4 h. Wells were replaced with 200 µL isopropanol-HCl 
and the absorbance measured in Tecan Infinite M200 Pro microplate 
reader at 570 nm. Relative viabilities were calculated according to the 
equation [A]test/[A]control × 100, in which A is absorbance and untreated 
cells served as a control. All experiments were performed in triplicates 
(mean ± s.d, n = 3).
In Vitro Transfection Efficiency Assay of pEGFP-N3/1An and pEGFP-
N3/2An Polyplexes: HeLa cells were plated in 24-well plates at 5 × 
104 cells per well, in 500 µL complete RPMI medium containing 10% 
FCS, 1% antibiotics, and 1% nonessential aminoacids (NEAA). After 
24 h, medium was changed to a 500 µL per well fresh medium without 
FBS. Then, cells were treated with 25, 50, 75, and 100 µL of previously 
prepared polyplexes, 500 µL final volume, for 6 h incubation (37 °C and 
5% CO2). Medium was changed to fresh complete medium and after 
48 h, cells were washed with PBS and detached with trypsin/EDTA 
solution. Detached cells were transferred to a flow cytometry tube, 
centrifuged for 5 min at 140 g and resuspended in PBS. An Accuri C6 
(Becton Dickinson, Heidelberg, Germany) flow cytometer and BD Accuri 
C6 Software were used for the data acquisition. Data was analyzed by 
FlowJo V10 flow cytometry analysis software. All experiments were 
performed in triplicates (mean ± s.d., n = 3).
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